ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,098,000 | +88.2% | 174,800 | -1.0% | 0.07% | +76.2% |
| Q1 2019 | $4,303,000 | +72.5% | 176,500 | +0.8% | 0.04% | +50.0% |
| Q4 2018 | $2,495,000 | -14.5% | 175,100 | -8.8% | 0.03% | -3.4% |
| Q3 2018 | $2,919,000 | -9.3% | 192,100 | +0.2% | 0.03% | -14.7% |
| Q2 2018 | $3,218,000 | +3.4% | 191,800 | +0.5% | 0.03% | -2.9% |
| Q1 2018 | $3,113,000 | +40.1% | 190,800 | +9.9% | 0.04% | +20.7% |
| Q4 2017 | $2,222,000 | +4.1% | 173,600 | 0.0% | 0.03% | 0.0% |
| Q3 2017 | $2,135,000 | +59.9% | 173,600 | +8.8% | 0.03% | +52.6% |
| Q2 2017 | $1,335,000 | – | 159,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |